+ Watch ROCM
on My Watchlist
Develops, manufactures and markets a line of innovative, technologically enhanced PVC-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets.
Stock has pulled back to the $24 range where it has value. Aging population spells long term growth for their medical (catheter) business. Look for continued earnings/revenue growth over next two years - volatile, but good chance to outperform.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions